1 completed, 1 terminated. 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Terminated 1 |
Follow 3B Pharmaceuticals GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-NTA-476 Imaging in Prostate Cancer 68Ga-NTA-476 - Prostate Cancer | Early Phase 1 | Completed | Melbourne Theranostic Innovation Centre | 10 | 2024-09-13 | 2025-09-25 |
| A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours [225]-FPI-2059, [111In]-FPI-2058 - Pancreatic Ductal Adenocarcinoma (PDAC), Squamous Cell Carcinoma of Head and Neck | Phase 1 | Terminated | 3B Pharmaceuticals GmbH | 19 | 2023-02-07 | 2025-08-24 |
Prostatic Neoplasms (2) · Carcinoma, Squamous Cell (1) · Colorectal Neoplasms (1) · Sarcoma, Ewing (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1)
Australia (2) · United States (1)
Aaron Enke (1) · Prof.Rod Hicks, MB BS, MD, FRACP, FICIS (1)